Search results

Information technologies are deeply involved in shaping the contemporary human condition and its social organization. To a certain extent, these technologies are "micro-politics" that endorse, in their concepts and conceptions, moral and political choices affecting our relations with ourselves, with others and with the world. They are both a social construction and a social constraint.

How can teleworking and face-to-face work be reconciled? How can these professional practices be framed to reinforce the innovative and sustainable dimensions of hybrid work? These are the questions that Michel Ajzen, a specialist in organizational management, is tackling as part of his teaching assignments in the Department of Management Sciences at UNamur. His research focuses on hybrid work and organizational innovation, with a transdisciplinary approach aimed at reinventing managerial practices to meet contemporary challenges.

On 13 December 2023, Charlotte Beaudart, a new academic at the University of Namur Faculty of Medicine, will be awarded a prize at the annual ceremony for Belgian scientific research in support of her innovative research on the subject of ageing.

TEF-Health: Testing and Experimentation Facilities for Health AI and Robotics is a major European project aimed at the rapid adoption of solutions based on artificial intelligence and robotics in the medical sector. UNamur, with the expertise of its Centre de Recherche Information Droit et Société (CRIDS), is a partner in this project.

The University of Namur is involved in the European CERTAINTY project, an initiative led by the German Fraunhofer Institute to explore new avenues in cancer treatment. Launched in December 2023, this European consortium is funded by the European Union - Horizon Europe program - to the tune of almost 10 million euros over the next 4.5 years.

The annual conference of Trail, the structure that brings together all artificial intelligence researchers in the Wallonia-Brussels Federation, and entitled "Inclusion, Parcimony and Plurality: the Future of AI?", was held at UNamur on May 14. 150 participants came to listen to a particularly rich and varied program.

The Elongator complex is involved in the addition of 5'-carboxylmethyluridine (cm5U)-derived modifications to transfer RNAs (tRNAs), thereby influencing the translation of certain messenger RNAs (mRNAs) and helping to maintain the integrity of the proteome. This complex is involved in a variety of biological processes, and is of particular importance in oncology. The identification of chemical inhibitors of Elongator is of significant interest in both basic and pharmaceutical research.Through a yeast screen, this work reveals a potential new role for Elongator and identifies a chemical inhibitor of the complex. This compound presents itself as an interesting candidate as a pharmacological inhibitor, opening up new perspectives for the search for anti-cancer therapies.

In 1996, the European Union created the Marie Skłodowska-Curie Actions (MSCA), a set of prestigious and competitive grants designed to fund research. Thanks to her, the PROSTAMET project got underway on January 1, an ambitious program focused on training PhD students and discovering new therapeutic avenues against prostate cancer, in which UNamur is participating.

At UNamur's NARILIS Institute, the 'Stress and AGEing' (SAGE) research group, led by Professor Florence Chainiaux, is seeking to understand the biological processes involved in ageing, focusing on the interconnection between exposure to stress and cellular senescence.

Catherine Michaux, a qualified FNRS researcher, is a partner in the European MSCA-Doctoral Network PROSTAMET project. The special feature of this project is that it funds both research and the training of 9 doctoral students within a network of multidisciplinary experts.

More info coming soon! More info on the NARILIS website

A multidisciplinary research team from the University of Namur (UNamur) and the UCL Namur University Hospital (Godinne campus) has just published a study in the journal Acta Neuropathologica that sheds light on some of the mysteries surrounding the origin of the pain experienced by patients with long COVID. Their findings suggest that these painful symptoms may be mediated by an autoimmune response. In other words: patients produce antibodies that attack their own neurons—those responsible for pain perception and deep body sensation, located along the spine. These highly promising results represent a major scientific breakthrough that opens new avenues for better understanding the disease and, ultimately, developing a treatment targeting the painful symptoms of long COVID.